lapatinib,capecitabine,trastuzumab emtansine,trastuzumab,trastuzumab deruxtecan
roche,daiichi sankyo,astrazeneca
['destiny,breast,2', 'breast', 'trastuzumab deruxtecan', 'destiny,breast,3', 'bcsm', 'rux,(-crux),(-trux)']
dr. ian krop shared an overview of the #destiny clinical trials, establishing trastuzumab deruxtecan as standard of care for her2-low metastatic #breastcancer. #asco23 #bcsm 
Yale Cancer Center is a collaboration between renowned cancer researchers and physicians @Yale and @SmilowCancer.